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Aim: To adapt, translate, and utilize the Dimensional Apathy Scale (DAS) in Amyotrophic
Lateral Sclerosis (ALS) to the Spanish population.
Method: We recruited 104 ALS patients (67 of their caregivers) and 49 controls.
Participants completed the Spanish-translated DAS, Geriatric Depression Scale-
Short form. Patients were also administered the ALS Functional Rating Scale-
Revised (ALSFRS-R). Caregivers additionally completed the informant/caregiver-rated
Spanish-translated DAS. The DAS was translated to Spanish using a back-translation
method. Test-retest and internal consistency reliability were examined. Divergent validity
was assessed by comparing the DAS with the depression scale (GDS-15). Principal
Component Analysis (PCA) was applied to explore the substructure of the Spanish DAS.
Results: The internal consistency reliability of self-rated Spanish DAS was 0.72
and of the informant/caregiver-rated Spanish DAS was 0.84. Correlations between
self-rated DAS subscales and GDS-15 were not statistically significant, with a good
test-retest reliability. PCA analysis showed a similar substructure to the original DAS.
ALS patients had significantly higher Initiation apathy than controls. Additionally, ALS
patient informant/caregiver-rated DAS Emotional apathy was significantly higher than
the self-rated, with no significant differences observed in the Executive and Initiation
subscales. No association was found between DAS and functional impairment using
the ALS Functional Rating Scale (ALSFRS-R).
Conclusion: The Spanish translation of the DAS is valid and reliable for use in assessing
multidimensional apathy in the Spanish population. Availability of the Spanish DAS will
allow for future research to explore different apathy subtypes and their impact in ALS and
other conditions.
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INTRODUCTION
Many studies show that apathy is the most common and
relevant behavioral symptom in patients with Amyotrophic
Lateral Sclerosis (ALS) (1), and it’s estimated to be present in
31–56% of patients (2–5). Apathy has been linked to cognitive
impairment, as well as to worse prognosis in ALS patients (6).
This symptom is measured using tests that do not take into
consideration the physical impairment of patients, such as the
Frontal Systems Behavior Scale (FrSBe) (7), or it is assessed
globally as part of other behavioral and psychiatric disorders as
is the case of the Cambridge Behavioral Inventory revised (CBI-
R) (8), the ALS Frontotemporal Dementia Questionnaire (ALS-
FTD-Q) (9), or, lastly, the Motor Neuron Disease Behavioral
Instrument (MiND-B) (10). However, apathy is established as a
multidimensional construct, composed of different subtypes or
domains with different cognitive and neurobiological substrates
[e.g., (11, 12)]. Apathy as a syndrome has been further recognized
in terms of assessment, diagnosis, and management (13–15).
The Dimensional Apathy Scale (DAS) (13) was developed
to measure different subtypes of apathy, accounting for
physical disability. The DAS quantifies three subtypes of
apathy, executive apathy (lack of motivation for planning,
organization, and attention); emotional apathy (emotional
flatness, blunting, indifference, or neutrality); and initiation
apathy (lack of motivation for self-generation of thoughts and/or
actions). Initiation apathy, independent of physical disability,
has been observed to be characteristic in ALS (16, 17) and
has been associated with characteristic cognitive deficits (18).
Comparatively different from profiles manifested by other
neurodegenerative diseases such as Alzheimer’s disease and
Parkinson’s disease (12). The DAS is a fast, simple, and easily
understandable measure of multidimensional apathy that can be
used both in the clinical context and in research. Thus, far the
DAS has been validated in Italian, French, and Japanese (19–21),
with no Spanish translation available.
The aim of this study was to validate the translation of DAS to
the Spanish population. Additionally, the aim was to explore the
profile of apathy in Spanish ALS patients.
METHODS AND MATERIALS
Participants
We recruited 104 ALS patients (61 male and 43 female), as well as
67 of their caregivers, using a convenience sampling method via
the ALS Unit at the La Paz-Carlos III Hospital, Madrid, Spain,
a multidisciplinary care and research facility. All patients were
diagnosed with probable or definite ALS (22). The exclusion
criteria for patients were tracheostomy or use of noninvasive
ventilation for more than 2 h during waking hours at the time
of the study, other neurological impairment, brain injury, or
psychiatric illness and history of substance abuse. In all, 11 ALS
patients declined to take part in the research, and one passed
away during the study.
Caregivers must provide regular care and have substantial
contact with the patient participant. The caregivers had a
minimum of 10 h total and at least 3 days contact per week with
the patient participant.
We also recruited 49 controls (21 male and 28 female)
using a convenience sampling method and included friends,
family, salaried caregivers, or spouses of patients. The exclusion
criteria for controls were a prior clinical history of neurological
impairment/dysfunction or psychiatric illness.
Procedures and Measures
Both the patient and the control groups provided demographics
information and completed self-rated measures of apathy
(Dimensional Apathy Scale) and depression (Geriatric
Depression Scale- Short Form), as well as a measure of
functional disability (ALS Functional Rating Scale-Revised) and
a cognitive screen (Edinburgh Cognitive and Behavioral ALS
Screen). All measures could be completed either by writing
or verbally, to allow for varying physical disability and disease
stages associated with ALS. The caregiver group informant-
caregiver-rated versions of the Dimensional Apathy Scale
(Informant/caregiver-rated versions), as well as a behavioral
interview (Edinburgh Cognitive and Behavioral ALS Screen),
about their observations of the patients. Please see below for
descriptions of the measures.
The Dimensional Apathy Scale [DAS; (16, 23)] is composed
of three subscales assessing different dimensions of apathy:
Executive, Emotional, and Initiation. Each item is answered
on a 4-point Likert scale of frequency in the last month. The
maximum score for each subscale ranges from 0 (no apathy)
to 24 (most apathy). Clinical cutoffs were available: executive
apathy ≥14, emotional apathy ≥15, and initiation apathy ≥16
(16). Both self-rated and informant/caregiver-rated versions
are available and were translated into Spanish using a back-
translation method by a professional bilingual translator. This
was then reviewed by two ALS experts before finalization. Please
see Supplementary Material for the Spanish DAS (self-rated and
informant/caregiver-rated versions) and scoring sheets.
The Geriatric Depression Scale-Short Form [GDS-15; (24)] is
composed of 15 items answered dichotomously (Yes/No) based
on the occurrence of depressive symptoms during the previous
week. The total score ranges from 0 (no depressive symptoms) to
15 (high depressive symptoms), with the cutoff score set at 5. A
Spanish translation was available (25).
The Edinburgh Cognitive and Behavioral ALS Screen [ECAS;
(26)] assesses cognitive functions (executive functions, social
cognition, verbal fluency, language, memory, and visuospatial
function), producing a score ranging from 0 to 136, with lower
scores indicating more cognitive impairment. The ECAS also
contains a behavioral interview to be completed by the caregiver
about the patient to determine presence of behavioral symptoms
(e.g., disinhibition, apathy, loss of sympathy and empathy,
perseverative/ritualistic behavior, altered food preference, and
psychosis). A Spanish translation was available (27).
The ALS Functional Rating Scale-Revised [ALSFRS-R; (28)]:
ALSFRS-R is a tool designed to measure disease progress in ALS
patients. It consists of 12 items, each scored on a 5-point Likert
scale assessing functional disability, with a total score ranging
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from 0 (least functional ability) to 48 (most functional ability).
A Spanish translation was available (29).
The study received institutional ethical approval by the
researchers at Institute University Hospital La Paz (IdiPAZ).
All patient, control, and caregiver participants gave informed
consent following the Declaration of Helsinki.
Statistical Analysis
R software was used for statistical analysis. The Shapiro-Wilk
test was used as a test of normality to determine whether the
analysis should be parametric or nonparametric. Demographic
variables comparison between ALS patients and controls was
assessed through t-tests (age) and chi-square tests (sex and
education level). Internal consistency reliability was assessed
using Cronbach’s standardized alpha. Intraclass correlation (ICC)
was used in order to determine the self-rated DAS test-retest
reliability in the patient group in a 1-month interval. Spearman’s
correlation coefficient (Holm corrected) was used to examine
correlations between DAS subscales, DAS Total and with GDS-
15. The Mann Whitney U test was used to distinguish, on
the DAS Total score, between individuals with apathy and
those without (according to the ECAS behavior interview,
apathy/inertia domain).
To determine the number of factors extracted based on own
values, Horn’s parallel analysis of principal factors was used. To
determine the substructure of the scale, a Principal Components
Analysis (PCA) was performed on the self-rated DAS in Spanish.
Derivative factors overlapping and the original DAS subscales
were analyzed (% mapped). The scores for the PCA’s derived
factors were calculated, and in order to determine overlapping,
Spearman’s correlation coefficient was applied using the original
scores for the self-rated Spanish DAS.
The ALS patients’ DAS scores were compared to the caregivers
scores using t-tests. For the control comparison, the ALS patients
were subsampled to match the control group for age, sex, and
education, utilizing previously used subsampling methodology
(16). To further determine the apathy profile, DAS scores of
the ALS subsample group and control group were compared
using t-tests.
RESULTS
Demographic and Clinical Variables
Table 1 shows demographic and clinical descriptors of ALS
patients and controls. ALS patients were significantly older
than controls. There was no significant difference between ALS
patients and controls on sex, education, and depression. It was
found that 30.2% of ALS patients were above the cutoff for
depression, compared with 22.5% of controls. Further, the most
common relationship to the caregiver was that of spouse (n =
48), followed by other relatives (n = 15), and finally by friends,
formal caregivers, and other relationships (n= 4).
Reliability, Validity, and Substructure
Cronbach’s standardized alpha was 0.72 for the self-rated Spanish
DAS and 0.84 for the informant/caregiver-rated Spanish DAS,
pointing to a high internal consistency. The reliability test-retest
TABLE 1 | Demographic and clinical data of ALS patients and controls.
ALS patients
(n = 104)
Control
(n = 49)
Statistics p-value
Age (mean ± SD) 59.9 ± 11.6 53.2 ± 10.5 t = 3.52 <0.001
Sex (male/female) 61/43 21/28 χ2 = 3.34 n.s.
Education
Without university
degree % (n)
59.6 (62) 51.0 (25) χ2 = 2.45 n.s.
With university degree
% (n)
32.7 (34) 44.9 (22)
Unknown % (n) 7.7 (8) 4.1 (2)
GDS-15 (mean ± SD) 3.9 (3.1)†† 3.1 (2.8) T = −1.40 n.s.
Duration of symptoms,
months
23.31 (29.63)
Median, IQR 15 (15)
Onset region
Spinal % (n) 68.2 (71)
Bulbar % (n) 30.8 (32)
Respiratory % (n) 1 (1)
ALSFRS-R (mean ±
SD)/48
32.2 ± 8.5†
Cognitive ECAS, Total
(mean ± SD)/136
104.5 ± 21.7‡
Behavioral ECAS
(median, IQR)/5
0 (1)‡‡
†n = 96; ††n = 96; ‡n = 55; ‡‡n = 56.
for the patient group (n = 75) for the self-rated DAS subscales
was excellent (ICC Executive= 0.85, ICC Emotional= 0.75, ICC
Initiation = 0.87). The median of the number of days between
test and retest was 30 (IQR= 73).
The correlation between the self-rated DAS subscales
showed a similar pattern than that of the original DAS (23),
with significant correlations between Initiation and Executive
apathy, but these correlations were not observed between
Executive and Emotional apathy (Table 2). In terms of divergent
validity, neither the self-rated and informant/caregiver-rated
DAS subscales nor the DAS total score showed a significant
correlation with the depression scale (GDS-15), as shown in
Table 2. Further, the informant/caregiver-rated DAS showed
significant correlations were observed between the Initiation
and Executive subscales, as well as for Initiation and Emotional
(see Table 2). No significant correlation was found when
comparing the self-rated and informant/caregiver-rated DAS
with the ALSFRS-R.
Further, a subset of ALS patients and their caregivers (n
= 39) completed both the ECAS behavioral interview and the
informant/caregiver-rated DAS. Based on the ECAS behavioral
interview, patients with apathy/inertia (n= 8) had a significantly
higher (U = 65, p < 0.05) informant/caregiver-rated DAS
Total score (Median = 31.5) than those without apathy/inertia
(Median = 24), showing good convergent validity. No such
difference was observed with the self-rated DAS.
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TABLE 2 | Correlation between DAS subscales (self-rated and informant carer rated) and GDS-15 for patients.
Self-rated
(n = 104)
DAS
Executive
DAS
Emotional
DAS
Initiation
DAS Total Self-rated
GDS-15
DAS Executive 1.000 0.097 0.373** 0.704*** 0.064†
DAS Emotional 1.000 0.189 0.480*** −0.038†
DAS Initiation 1.000 0.814*** 0.128†
DAS Total 1.000 0.096†
Informant/caregiver-rated
(n = 67)
DAS
Executive
DAS
Emotional
DAS
Initiation
DAS Total Self-rated
GDS-15
DAS Executive 1.000 0.189 0.579*** 0.720*** 0.276‡
DAS Emotional 1.000 0.415** 0.657*** 0.047‡
DAS Initiation 1.000 0.657*** 0.248‡
DAS Total 1.000 0.230‡
†n = 86, ‡n = 66; *p < 0.05; **p < 0.01; ***p < 0.001.
A PCA with a Varimax rotation (orthogonal) was used,
since the factors were not correlated. Horn’s parallel analysis
determined that three factors should be extracted. Kaiser-Meyer-
Olkin’s test (KMO) and themeanMeasure of Sampling Adequacy
(MSA) showed that the sample can be factored (KMO = 0.665,
mean MSA = 0.638). This was backed by a significant value for
Bartlett’s test of sphericity (p < 0.001). The cumulative three
factors solution represented 36.1% of total variance and the
factors were subsequently labeled according to the content of
their items (Table 3). In general, 79% of the items saliently loaded
to the original item 24 from DAS. In terms of the AES subscales,
87.5% of the items were correctly assigned to the Initiation and
Executive subscales, with 37.5% of the items in the Emotional
subscale. Additionally, correlation analysis showed significant
positive correlations between self-rated DAS subscales and the
corresponding PCA derived scores.
Apathy Profile
There was no significant difference in age between the ALS
patient subsample (Mean = 54.9, SD = 10.5) and controls
(Mean= 53.2, SD= 10.5). Additionally, there was no significant
difference in education level between the ALS patient subsample
(36.7% university educated) and controls (44.9% university
educated). The ALS patient subsample was perfectly matched to
the control sample by sex.
The ALS subsample group was found to have significantly
higher Initiation apathy than controls, with no significant
differences were observed on Executive and Emotional apathy
(see Figure 1).
The informant/carer-rated DAS Emotional apathy subscale
(Mean = 9.22, SD = 4.04) scores was significantly higher than
the patient self-rating (Mean = 7.12, SD = 3.16) scores [t(66) =
3.268, p < 0.01]. No significant difference was found on DAS
Executive apathy subscale scores between informant/caregiver-
ratings (Mean= 5.61, SD= 4.29) and self-ratings (Mean= 5.70,
SD = 4.45). There was no significant difference on the DAS
Initiation apathy subscale scores between informant/caregiver-
ratings (Mean= 10.01, SD= 6.19) and self-ratings (Mean= 9.37,
SD= 4.78).
Normative data were used to suggest abnormal value
thresholds for each subscale based on ≥2 SD over the mean
(see Supplementary Table 1). Based on normative data, 12.2% of
the ALS subsample group showed Initiation apathy, with 4.1%
showing Executive apathy and 4.1% showing Emotional apathy.
According to previously published cutoffs (16), 16.3% of the ALS
subsample group showed Initiation apathy, with 4.1% showing
Executive apathy and 2.0% showing Emotional apathy.
DISCUSSION
The Spanish DAS was found to be reliable and valid for the
assessment of apathy subtypes. The substructure of the self-
rated Spanish DAS was similar to that of the original DAS,
providing support for it as a multidimensional measure. Further,
exploration of the apathy profile in the Spanish ALS patients
showed results similar to those of previous research (16, 17),
with Initiation apathy (lack of motivation for self-generation of
thoughts and/or actions) being characteristic and independent of
physical disability.
Psychometrically, the self-rated Spanish DAS subscales all
showed a good test-retest reliability, showing a relative stability
of apathy subtypes in ALS patients. In terms of divergent validity,
both the self-rated and informant/caregiver-rated DAS subscales
were not associated with depression. In particular, the DAS
Emotional apathy has previously been observed to have no
association or a weak association with depression in ALS (16, 17),
which has also been found for the Italian, Japanese, and French
translations of the DAS (19–21). This adds support to the notion
of Emotional apathy (i.e., emotional neutrality) and depression
(i.e., emotionality) as disparate constructs. Moreover, the lack of
association of Initiation and Executive apathy subscales against
depression suggests that measurement of apathy with the Spanish
DAS is independent of the confounding factor of depression.
However, as with previous research, it is important to continue
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TABLE 3 | Orthogonal rotation PCA (principal components analysis) for self-rated
Spanish DAS item responses (n 104), mapping, and correlation of principal
components to original DAS in ALS patients.
PC 1
(Initiation)
PC 2
(Executive)
PC 3
(Emotional)
D13BCI 0.770 −0.177 0.005
D4BCI 0.725 0.202 −0.045
D14BCI 0.592 0.116 −0.212
D16BCI 0.575 −0.127 0.142
D18BCI 0.553 0.339 0.239
D8BCI 0.490 0.035 0.291
D2BCI 0.413 0.144 0.158
D19Ex −0.231 0.682 −0.01
D6Ex 0.078 0.681 0.030
D21Ex 0.108 0.673 0.391
D23Ex −0.026 0.583 0.128
D17Ex 0.237 0.520 −0.105
D11Ex 0.610 0.448 −0.079
D1Ex 0.253 0.470 −0.042
D5Em 0.058 −0.043 0.684
D7Em 0.226 −0.227 0.550
D24Em 0.015 0.115 0.403
D3Em 0.534 0.005 −0.464
D10Ex 0.354 0.271 0.436
D12Em 0.121 0.158 0.056
D9Em −0.007 −0.120 0.154
D15Em −0.003 0.298 −0.135
D20Em −0.233 −0.016 0.033
D22BCI 0.234 −0.121 −0.502
Proportion of variance 0.153 0.122 0.086
Cumulative variance 0.153 0.275 0.361
% Mapping of original
DAS subtypes
(loadings ≥ 0.30)
87.5 87.5 37.5
Correlations of
PC-derived subscale
scores to self-rated
DAS
PC 1 (Initiation) PC 2
(Executive)
PC 3
(Emotional)
Self-rated DAS Initiation 0.974*** 0.321*** 0.097
Self-rated DAS
Executive
0.389*** 0.984*** 0.028
Self-rated DAS
Emotional
0.178 0.090 0.652***
Self-rated DAS Total 0.810*** 0.659*** 0.294***
In gray are those most applicable to each factor. Those considered relevant are shown in
bold characters (≥ 0.30). PC, principal component. *p < 0.05; **p < 0.01; ***p < 0.001.
to measure apathy and depression together, as the constructs
occur concurrently and have variable impacts (30). In terms of
the intercorrelations of the Spanish DAS subscales, Executive
and Initiation apathy seemed to be associated most consistently
across the informant/caregiver-ratings and self-ratings. This
is likely due to overlapping executive processes underlying
motivation for initiation and planning/organizing/attention
(12, 31).
While the self-rated Spanish DAS showed good internal
consistency reliability, the informant/caregiver-rated version
was observed to have higher internal consistency reliability.
This is very much in line with previous research from ALS
and dementia (16, 32), indicating the informant/caregiver-
rated version is more psychometrically reliable. Furthermore,
ALS patients with apathy/inertia (based on the semi-structured
ECAS behavioral interview) had higher informant/caregiver-
rated Spanish DAS scores, showing good convergent validity.
However, no such difference was found for the self-rated Spanish
DAS. Variable awareness of, or insight into, behavior problems
and/or changes is characteristic of frontotemporal dementia
associated with ALS (33), which may influence patients’ self-
ratings. As a result, the informant/caregiver-rated DAS was
used to design the informant/caregiver-rated brief DAS (34, 35),
a short and comprehensive apathy subtype measure with a
supplemental awareness assessment. Future research should look
to translate and utilize the brief DAS clinically to help detect
motivational problems.
The substructure of the self-rated Spanish DAS has a high
mapping percentage to the original DAS substructure (23)
and to previous translations (19–21). The moderate to strong
association between PC-derived subscores with relevant DAS
subscores further provides support for the claim that the
Spanish DAS is a valid instrument for multidimensional apathy
assessment. The three-dimensional factor structure (akin to the
original DAS) showed high mapping percentages relative to
DAS Executive and Initiation subscales. The Emotional subscale
was observed to map at a lower percentage; however, the
items that did map were those included as a part of the b-
DAS (items 5, 7, and 24) (34). The French translation of
the DAS suggested that the Emotional apathy construct is
more multifaceted, where further subcomponents of “individual”
and “social” Emotional apathy might be of importance (20).
Therefore, further transcultural research would be beneficial to
understand how Emotional apathy is perceived and expressed in
different countries.
Apathy profile exploration showed that Initiation apathy
was observed to be characteristic in ALS when compared
with matched controls, in line with previous findings (16,
17). Initiation apathy was also observed to be the higher in
terms of DAS subscale cutoffs, albeit at a lower prevalence.
The availability of culturally specific cutoffs will enable more
specific exploration of apathy subtypes in the Spanish population.
Emotional apathy was rated as higher by informant/caregivers,
when compared to patient self-ratings, which could suggest
lower awareness or insight of this apathy subtype. Research
has further suggested that both Emotional apathy and lower
awareness of Emotional apathy are observable in behavioral
variant FTD (36); therefore, it would be of interest to explore
apathy subtype profiles (specifically Emotional apathy) across
ALS-frontotemporal spectrum disorders (ALS-FTSD) (33).
While the Spanish DAS has been shown to be valid and
reliable, at the time of data collection there were no comparable
valid “gold-standard” apathy measures available in Spanish as
comparators, which prevented full convergent validity from
being determined. This, however, did not limit the development
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FIGURE 1 | DAS subscales comparisons between ALS patient subsample (n = 49) and control (n = 49) groups.
of the original DAS and the French translation (20, 23). In
the ECAS behavior interview the apathy/inertia domain was
additionally utilized for validation of the informant/caregiver-
rated Spanish DAS. Future research should explore the
sensitivity, specificity, and predictive validity of the Spanish
DAS to further determine its clinical utility. The convenience
recruitment method utilized may also have biased the sample
and, as with other apathy research, may have introduced a
volunteerism bias. However, this is unlikely to impact the Spanish
DAS validation results as previous DAS validation research has
used similar recruitment methodology (16, 21, 35). Furthermore,
there was an age difference between the ALS patient group
and the control group. In terms of apathy profile results,
previous subsampling methodology (16) was utilized to ensure
the matching of ALS patients and controls with respect to age,
sex, and education, for a more robust comparison.
In conclusion, the Spanish DAS is a psychometrically robust
instrument for assessing multidimensional apathy, with three-
dimensional factorial substructure. Further, Initiation apathy
was found to be characteristic in Spanish ALS patients. Future
research should look to further explore the clinical impact
of apathy subtypes in different neurological, psychiatric, and
neurodegenerative conditions.
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